1. Home
  2. NTGR vs RCUS Comparison

NTGR vs RCUS Comparison

Compare NTGR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTGR
  • RCUS
  • Stock Information
  • Founded
  • NTGR 1996
  • RCUS 2015
  • Country
  • NTGR United States
  • RCUS United States
  • Employees
  • NTGR N/A
  • RCUS N/A
  • Industry
  • NTGR Telecommunications Equipment
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTGR Utilities
  • RCUS Health Care
  • Exchange
  • NTGR Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • NTGR 820.0M
  • RCUS 906.4M
  • IPO Year
  • NTGR N/A
  • RCUS 2018
  • Fundamental
  • Price
  • NTGR $25.14
  • RCUS $9.07
  • Analyst Decision
  • NTGR Buy
  • RCUS Buy
  • Analyst Count
  • NTGR 1
  • RCUS 8
  • Target Price
  • NTGR $29.00
  • RCUS $20.71
  • AVG Volume (30 Days)
  • NTGR 562.2K
  • RCUS 731.3K
  • Earning Date
  • NTGR 07-30-2025
  • RCUS 08-06-2025
  • Dividend Yield
  • NTGR N/A
  • RCUS N/A
  • EPS Growth
  • NTGR N/A
  • RCUS N/A
  • EPS
  • NTGR 2.16
  • RCUS N/A
  • Revenue
  • NTGR $697,865,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • NTGR $4.48
  • RCUS N/A
  • Revenue Next Year
  • NTGR $5.04
  • RCUS $28.73
  • P/E Ratio
  • NTGR $11.62
  • RCUS N/A
  • Revenue Growth
  • NTGR 0.41
  • RCUS 6.07
  • 52 Week Low
  • NTGR $14.86
  • RCUS $6.50
  • 52 Week High
  • NTGR $31.55
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • NTGR 42.98
  • RCUS 46.54
  • Support Level
  • NTGR $21.59
  • RCUS $9.09
  • Resistance Level
  • NTGR $26.10
  • RCUS $10.74
  • Average True Range (ATR)
  • NTGR 1.11
  • RCUS 0.55
  • MACD
  • NTGR -0.00
  • RCUS -0.06
  • Stochastic Oscillator
  • NTGR 57.26
  • RCUS 12.11

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: